Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Stock Options (Details)

v3.23.1
Stockholders' Equity - Stock Options (Details) - Stock Options - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Stockholders' Equity      
Stock options, Outstanding (beginning) 27,000 22,000  
Stock options, Granted 4,000 5,000  
Stock options, Forfeited (4,000)    
Stock options, Outstanding (ending) 27,000 27,000 22,000
Vested and exercisable as of December 31, 2022 15,500    
Weighted Average Exercise Price, Outstanding (beginning) $ 31.35 $ 32.00  
Weighted Average Exercise Price, Granted 14.20 28.50  
Weighted Average Exercise Price , Forfeited 14.20    
Weighted Average Exercise Price, Outstanding (ending) 31.35 $ 31.35 $ 32.00
Weighted Average Exercise Price, Vested and exercisable as of December 31, 2022 $ 23.06    
Weighted Average Remaining Contractual Life, Outstanding (in years) 6 years 5 months 8 days 7 years 5 months 8 days 8 years 14 days
Weighted Average Remaining Contractual Life, Vested and exercisable (in years) 6 years 10 months 20 days